Related references
Note: Only part of the references are listed.Angiotensin II-induced reduction in exercise capacity is associated with increased oxidative stress in skeletal muscle
Naoki Inoue et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Oxidative stress impairs insulin signal in skeletal muscle and causes insulin resistance in postinfarct heart failure
Yukihiro Ohta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Telmisartan Improves Insulin Resistance and Modulates Adipose Tissue Macrophage Polarization in High-Fat-Fed Mice
Shiho Fujisaka et al.
ENDOCRINOLOGY (2011)
Lower aerobic capacity was associated with abnormal intramuscular energetics in patients with metabolic syndrome
Takashi Yokota et al.
HYPERTENSION RESEARCH (2011)
Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway
Xiaoli Feng et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Histochemical analysis of muscle fiber types of rat superior rectus extraocular muscle
Rashed M. Rashed et al.
ACTA HISTOCHEMICA (2010)
Valsartan Protects Pancreatic Islets and Adipose Tissue From the Inflammatory and Metabolic Consequences of a High-Fat Diet in Mice
Banumathi K. Cole et al.
HYPERTENSION (2010)
Oxidative stress in skeletal muscle impairs mitochondrial respiration and limits exercise capacity in type 2 diabetic mice
Takashi Yokota et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Angiotensin II Reduces Mitochondrial Content in Skeletal Muscle and Affects Glycentic Control
Masanori Mitsuishi et al.
DIABETES (2009)
Possible contribution of the non-proteolytic activation of prorenin to the development of insulin resistance in fructose-fed rats
Yukiko Nagai et al.
EXPERIMENTAL PHYSIOLOGY (2009)
Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy
Jeong Hun Kim et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Candesartan Improves Maximal Exercise Capacity in Hypertensives: Results of a Randomized Placebo-Controlled Crossover Trial
Maria Leonarda De Rosa et al.
JOURNAL OF CLINICAL HYPERTENSION (2009)
Diabetes Complications and the Renin-Angiotensin System.
Bruce A. Perkins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Bezafibrate, a peroxisome proliferator-activated receptors agonist, decreases body temperature and enhances electroencephalogram delta-oscillation during sleep in mice
Sachiko Chikahisa et al.
ENDOCRINOLOGY (2008)
Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients
Vadde Ramakrishna et al.
ACTA DIABETOLOGICA (2008)
Fatty acids increase the circulating levels of oxidative stress factors in mice with diet-induced obesity via redox changes of albumin
Mayumi Yamato et al.
FEBS JOURNAL (2007)
Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes
Martin Mogensen et al.
DIABETES (2007)
Overexpression of glutathione peroxidase attenuates myocardial remodeling and preserves diastolic function in diabetic heart
Shouji Matsushima et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation
A. Kurata et al.
KIDNEY INTERNATIONAL (2006)
Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome
Christian K. Roberts et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Insulin-stimulated NADH/NAD+ redox state increases NAD(P)H oxidase activity in cultured rat vascular smooth muscle cells
Ming Yang et al.
AMERICAN JOURNAL OF HYPERTENSION (2006)
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes - A meta-analysis of randomized clinical trials
H Abuissa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure
ZY Yuan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice
J Suzuki et al.
JOURNAL OF HYPERTENSION (2005)
Limited exercise capacity in heterozygous manganese superoxide dismutase gene-knockout mice - Roles of superoxide anion and nitric oxide
S Kinugawa et al.
CIRCULATION (2005)
Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats
K Okada et al.
HYPERTENSION RESEARCH (2004)
c-Src induces phosphorylation and translocation of p47phox - Role in superoxide generation by angiotensin II in human vascular smooth muscle cells
RM Touyz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
New insights on oxidative stress and diabetic complications may lead to a causal antioxidant therapy
A Ceriello
DIABETES CARE (2003)
Oxidative stress mediates tumor necrosis factor-α-induced mitochondrial DNA damage and dysfunction in cardiac myocytes
N Suematsu et al.
CIRCULATION (2003)
Abnormality in fibre type distribution of soleus and plantaris muscles in non-obese diabetic Goto-Kakizaki rats
K Yasuda et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2002)
Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries - Regulation by angiotensin II
RM Touyz et al.
CIRCULATION RESEARCH (2002)
Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease
HR Gosker et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes
M Wei et al.
ANNALS OF INTERNAL MEDICINE (2000)
Coronary microvascular endothelial cell redox state in left ventricular hypertrophy - The role of angiotensin II
D Lang et al.
CIRCULATION RESEARCH (2000)
Role of angiotensin II in diabetic nephropathy
DJ Leehey et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
